BioVaxys Technology Corp.
BVAXF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $9 | $18 | $16 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $9 | $9 | $18 | $16 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.031 | -0.046 | -0.041 | -0.125 |
| % Growth | 32.2% | -12.2% | 67.2% | – |
| Operating Cash Flow | -$1 | -$0 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$1 |